1- Hospital Management Research Center, Iran university of medical sciences, Tehran, Iran.
2- Health Policy and Management Research Center, Department of Health Management and Economics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ,m.mousavihp93@gmail.com
3- Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
4- Health Policy and Management Research Center, Department of Health Management and Economics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
2- Health Policy and Management Research Center, Department of Health Management and Economics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, ,
3- Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
4- Health Policy and Management Research Center, Department of Health Management and Economics, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Abstract: (38 Views)
Introduction:
Sustainable pharmaceutical supply chain management in hospital pharmacies is a critical component of healthcare systems and requires a multidimensional approach. This study aimed to analyze the causal structure and interrelationships among factors affecting pharmaceutical supply chain sustainability, considering economic, social, and environmental dimensions in hospital pharmacies in Yazd City, Iran.
Methods:
This applied analytical study was conducted in two phases. First, factors influencing sustainable pharmaceutical supply chain management were identified using a questionnaire developed based on the Supply Chain Operations Reference (SCOR) model, including five dimensions: reliability, responsiveness, flexibility, cost management, and asset management. The content validity of indicators was assessed using Lawshe’s content validity ratio (CVR), and the final indicators were validated by experts in pharmaceutical management and hospital pharmacy services. In the second phase, the fuzzy Decision-Making Trial and Evaluation Laboratory (Fuzzy DEMATEL) approach was used to determine causal relationships and prioritize influential factors.
Results:
Asset management and cost management were identified as the main causal and influential dimensions, whereas reliability, responsiveness, and flexibility were categorized as effect dimensions. At the indicator level, insufficient staffing, weak relationship management with distributors, ineffective performance of pharmacy and therapeutics committees, and inadequate cost–revenue analysis were among the most influential factors. The causal network map demonstrated complex interrelationships among the identified factors.
Conclusion:
This study provides a systematic understanding of causal relationships influencing sustainable pharmaceutical supply chains in hospital pharmacies. Strengthening asset and cost management, improving inventory systems, and enhancing organizational coordination may contribute to greater sustainability, resilience, and operational performance of pharmaceutical supply chains.
Sustainable pharmaceutical supply chain management in hospital pharmacies is a critical component of healthcare systems and requires a multidimensional approach. This study aimed to analyze the causal structure and interrelationships among factors affecting pharmaceutical supply chain sustainability, considering economic, social, and environmental dimensions in hospital pharmacies in Yazd City, Iran.
Methods:
This applied analytical study was conducted in two phases. First, factors influencing sustainable pharmaceutical supply chain management were identified using a questionnaire developed based on the Supply Chain Operations Reference (SCOR) model, including five dimensions: reliability, responsiveness, flexibility, cost management, and asset management. The content validity of indicators was assessed using Lawshe’s content validity ratio (CVR), and the final indicators were validated by experts in pharmaceutical management and hospital pharmacy services. In the second phase, the fuzzy Decision-Making Trial and Evaluation Laboratory (Fuzzy DEMATEL) approach was used to determine causal relationships and prioritize influential factors.
Results:
Asset management and cost management were identified as the main causal and influential dimensions, whereas reliability, responsiveness, and flexibility were categorized as effect dimensions. At the indicator level, insufficient staffing, weak relationship management with distributors, ineffective performance of pharmacy and therapeutics committees, and inadequate cost–revenue analysis were among the most influential factors. The causal network map demonstrated complex interrelationships among the identified factors.
Conclusion:
This study provides a systematic understanding of causal relationships influencing sustainable pharmaceutical supply chains in hospital pharmacies. Strengthening asset and cost management, improving inventory systems, and enhancing organizational coordination may contribute to greater sustainability, resilience, and operational performance of pharmaceutical supply chains.
Keywords: Sustainable Supply Chain Management, Hospital Pharmacy, Fuzzy DEMATEL, Network Analysis, Drug Supply Chain
Type of Study: Research |
Subject:
Health Services Management
Received: 2026/04/22 | Accepted: 2026/09/9
Received: 2026/04/22 | Accepted: 2026/09/9
References
1. Jambulingam T, Kathuria R. Antecedents to buyer-supplier coordination in the pharmaceutical supply chain. International Journal of Pharmaceutical and Healthcare Marketing. 2020;14(2):289-303.http://doi.org/10.1108/ijphm-08-2019-0058 [DOI:10.1108/IJPHM-08-2019-0058]
2. Campling N, Breen L, Miller E, Birtwistle J, Richardson A, Bennett M, et al. Issues affecting supply of palliative medicines into community pharmacy: A qualitative study of community pharmacist and pharmaceutical wholesaler/distributor perspectives. Exploratory Research in Clinical and Social Pharmacy. 2022;6:100132. [DOI:10.1016/j.rcsop.2022.100132]
3. Cavicchi C, Vagnoni E. Sustainable business models in hybrids: A conceptual framework for community pharmacies' business owners. Sustainability. 2020;12(19):8125. [DOI:10.3390/su12198125]
4. Lee YH, An D, Baek Y, Yoo K, Hyun S, Park S-K, et al. Factors influencing drug shortages and their resolution in South Korean community pharmacies. Risk Management and Healthcare Policy. 2024:2083-95. [DOI:10.2147/RMHP.S473859]
5. George S, Elrashid S. Inventory management and pharmaceutical supply chain performance of hospital pharmacies in Bahrain: a structural equation modeling approach. Sage Open. 2023;13(1):21582440221149717. [DOI:10.1177/21582440221149717]
6. Rizaldy FM, Handayati Y, Simatupang TM, Okdinawati L, Suharto Y, Ginanjar R. Comparative Analysis of Demand Forecasting Methods to Optimize Supply Chain Efficiency in PharmaHealth Group. International Journal of Current Science Research and Review. 2024;7(08):6271-6. [DOI:10.47191/ijcsrr/V7-i8-40]
7. Bahiru Tefera B, Tilahun Anbessa G. Pharmaceutical supply chain practices and its associated factors in public health facilities, West Gojjam Zone, Ethiopia: Cross-Sectional Study. Hospital Pharmacy. 2022;57(5):622-32. [DOI:10.1177/00185787211067375]
8. Shahbahrami E, Kalhor R, Amerzadeh M, Hasani M, Kiani M. A dynamic management model for sustainable drug supply chain in hospital pharmacies in Iran. BMC Health Services Research. 2024;24(1):1205. [DOI:10.1186/s12913-024-11692-8]
9. Agrawal A, Sharma A, Srivastava PK, Devi M, editors. Moving towards industry 5.0 for sustainable supply chain in the pharmaceutical industry. 2024 11th International conference on computing for sustainable global development (INDIACom); 2024: IEEE. [DOI:10.23919/INDIACom61295.2024.10498268]
10. Ali I, Kannan D. Mapping research on healthcare operations and supply chain management: a topic modelling-based literature review. Annals of Operations Research. 2022;315(1):29-55. [DOI:10.1007/s10479-022-04596-5]
11. Khan F, Ali Y. Implementation of the circular supply chain management in the pharmaceutical industry. Environment, Development and Sustainability. 2022;24(12):13705-31. [DOI:10.1007/s10668-021-02007-6]
12. Kumarswamy S, Sampigerayappa PA. Leveraging Blockchain Technology to Establish a Transparent and Counterfeit-Resistant Pharmaceutical Supply Chain. Journal Européen des Systèmes Automatisés. 2024;57(5). [DOI:10.18280/jesa.570518]
13. Sazvar Z, Tafakkori K, Oladzad N, Nayeri S. A capacity planning approach for sustainable-resilient supply chain network design under uncertainty: A case study of vaccine supply chain. Computers & Industrial Engineering. 2021;159:107406. [DOI:10.1016/j.cie.2021.107406]
14. Sharma A, Kumar D, Arora N. Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement. International Journal of Productivity and Performance Management. 2022;73(1):119-57.
https://doi.org/10.1108/IJPPM-01-2022-0035 [DOI:10.1108/ijppm-01-2022-0035]
15. Mohajer Tabrizi M, Khojeh Z, Darvishmohammadi T. Designing a drug distribution network using a two-tier genetic algorithm and priority-based coding The case of Adorateb. Research in Production and Operations Management. 2022;13(3):47-75. [in Persian] [DOI:10.22108/jpom.2022.133342.1439]
16. Shahbahrami E, Amoozad Mahdiraji H, Hosseinzadeh M. Prioritizing Determinants of Drug sustainable supply chain management in Hospital Pharmacies. Journal of Health Administration. 2020;23(2):89-101. [in Persian] http://jha.iums.ac.ir/article-1-3316-en.html [DOI:10.29252/jha.23.2.89]
17. Mehralian G, Moosivand A, Emadi S, Asgharian R. Developing a coordination framework for pharmaceutical supply chain: using analytical hierarchy process. International Journal of Logistics Systems and Management. 2017;26(3):277-93. [DOI:10.1504/IJLSM.2017.081961]
18. Nematollahi M, Hosseini-Motlagh S-M, Ignatius J, Goh M, Saghafi Nia M. Coordinating a socially responsible pharmaceutical supply chain under periodic review replenishment policies. Journal of Cleaner Production. 2018;172:2876-91. [DOI:10.1016/j.jclepro.2017.11.126]
19. Jaberidoost M, Nikfar S, Abdollahiasl A, Dinarvand R. Pharmaceutical supply chain risks: a systematic review. DARU Journal of Pharmaceutical Sciences. 2013;21(1):69. https://doi.org/ 10.1186/2008-2231-21-69 [DOI:10.1186/2008-2231-21-69]
20. Silva AC, Marques CM, de Sousa JP. A simulation approach for the design of more sustainable and resilient supply chains in the pharmaceutical industry. Sustainability. 2023;15(9):7254. [DOI:10.3390/su15097254]
21. Lawshe CH. A quantitative approach to content validity. Personnel psychology1975. Available from: https://parsmodir.com/wp-content/uploads/2015/03/lawshe.pdf
22. Akram W, Joshi R, Haider T, Sharma P, Jain V, Garud N, et al. Blockchain technology: A potential tool for the management of pharma supply chain. Research in Social and Administrative Pharmacy. 2024;20(6):156-64. https://www.sciencedirect.com/science/article/pii/S1551741124000792 [DOI:10.1016/j.sapharm.2024.02.014]
23. Ivanov D. The Industry 5.0 framework: viability-based integration of the resilience, sustainability, and human-centricity perspectives. International Journal of Production Research. 2023;61(5):1683-95. [DOI:10.1080/00207543.2022.2118892]
24. Rajeev A, Pati RK, Padhi SS, Govindan K. Evolution of sustainability in supply chain management: A literature review. Journal of Cleaner Production. 2017;162:299-314. https://www.sciencedirect.com/science/article/pii/S0959652617309514 [DOI:10.1016/j.jclepro.2017.05.026]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Site Keywords
Health, Administration, Scientific Article, Iran University of Medical Sciences,
